These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 23469954

  • 1. Functional effects of levosimendan in rat basilar arteries in vitro.
    Konczalla J, Mrosek J, Wanderer S, Schuss P, Guresir E, Seifert V, Vatter H, Platz J.
    Curr Neurovasc Res; 2013 May; 10(2):126-33. PubMed ID: 23469954
    [Abstract] [Full Text] [Related]

  • 2. Levosimendan, a new therapeutic approach to prevent delayed cerebral vasospasm after subarachnoid hemorrhage?
    Konczalla J, Wanderer S, Mrosek J, Gueresir E, Schuss P, Platz J, Seifert V, Vatter H.
    Acta Neurochir (Wien); 2016 Nov; 158(11):2075-2083. PubMed ID: 27614436
    [Abstract] [Full Text] [Related]

  • 3. Levosimendan Reduces Prostaglandin F2a-dependent Vasoconstriction in Physiological Vessels and After Experimentally Induced Subarachnoid Hemorrhage.
    Wanderer S, Mrosek J, Gessler F, Seifert V, Konczalla J.
    Curr Neurovasc Res; 2018 Nov; 15(1):72-80. PubMed ID: 29595109
    [Abstract] [Full Text] [Related]

  • 4. Coronary vasorelaxant effect of levosimendan, a new inodilator with calcium-sensitizing properties.
    Gruhn N, Nielsen-Kudsk JE, Theilgaard S, Bang L, Olesen SP, Aldershvile J.
    J Cardiovasc Pharmacol; 1998 May; 31(5):741-9. PubMed ID: 9593074
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure.
    Kivikko M, Lehtonen L.
    Curr Pharm Des; 2005 May; 11(4):435-55. PubMed ID: 15725064
    [Abstract] [Full Text] [Related]

  • 7. The vasodilatory effects of levosimendan on the human internal mammary artery.
    Montes FR, Echeverri D, Buitrago L, Ramírez I, Giraldo JC, Maldonado JD, Umaña JP.
    Anesth Analg; 2006 Nov; 103(5):1094-8. PubMed ID: 17056938
    [Abstract] [Full Text] [Related]

  • 8. Inhaled levosimendan reduces mortality and release of proinflammatory mediators in a rat model of experimental ventilator-induced lung injury.
    Boost KA, Hoegl S, Dolfen A, Czerwonka H, Scheiermann P, Zwissler B, Hofstetter C.
    Crit Care Med; 2008 Jun; 36(6):1873-9. PubMed ID: 18496375
    [Abstract] [Full Text] [Related]

  • 9. Alteration of the cerebrovascular function of endothelin B receptor after subarachnoidal hemorrhage in the rat.
    Konczalla J, Vatter H, Weidauer S, Raabe A, Seifert V.
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1064-8. PubMed ID: 16741050
    [Abstract] [Full Text] [Related]

  • 10. Cerebrovascular characterization of clazosentan, the first nonpeptide endothelin receptor antagonist shown to be clinically effective for the treatment of cerebral vasospasm. Part II: effect on endothelin(B) receptor-mediated relaxation.
    Vatter H, Zimmermann M, Tesanovic V, Raabe A, Seifert V, Schilling L.
    J Neurosurg; 2005 Jun; 102(6):1108-14. PubMed ID: 16028771
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Levosimendan increases diastolic coronary flow in isolated guinea-pig heart by opening ATP-sensitive potassium channels.
    Kaheinen P, Pollesello P, Levijoki J, Haikala H.
    J Cardiovasc Pharmacol; 2001 Apr; 37(4):367-74. PubMed ID: 11300649
    [Abstract] [Full Text] [Related]

  • 14. Crosstalk between the angiotensin and endothelin system in the cerebrovasculature after experimental induced subarachnoid hemorrhage.
    Wanderer S, Mrosek J, Vatter H, Seifert V, Konczalla J.
    Neurosurg Rev; 2018 Apr; 41(2):539-548. PubMed ID: 28756589
    [Abstract] [Full Text] [Related]

  • 15. Effective improvement of the cerebral vasospasm after subarachnoid hemorrhage with low-dose nitroglycerin.
    Ito Y, Isotani E, Mizuno Y, Azuma H, Hirakawa K.
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):45-50. PubMed ID: 10630732
    [Abstract] [Full Text] [Related]

  • 16. Calcium-dependent vasorelaxant capacity of levosimendan in porcine and human epicardial coronary artery preparations.
    Krassói I, Pataricza J, Kun A, Papp JG.
    Cardiovasc Drugs Ther; 2000 Dec; 14(6):691-3. PubMed ID: 11300371
    [No Abstract] [Full Text] [Related]

  • 17. Hemodynamic effect of intracoronary administration of levosimendan in the anesthetized pig.
    Grossini E, Caimmi PP, Molinari C, Teodori G, Vacca G.
    J Cardiovasc Pharmacol; 2005 Sep; 46(3):333-42. PubMed ID: 16116339
    [Abstract] [Full Text] [Related]

  • 18. Potassium channel-related relaxation by levosimendan in the human internal mammary artery.
    Yildiz O, Seyrek M, Yildirim V, Demirkilic U, Nacitarhan C.
    Ann Thorac Surg; 2006 May; 81(5):1715-9. PubMed ID: 16631661
    [Abstract] [Full Text] [Related]

  • 19. Vasodilating mechanisms of levosimendan: involvement of K+ channels.
    Yildiz O.
    J Pharmacol Sci; 2007 May; 104(1):1-5. PubMed ID: 17452812
    [Abstract] [Full Text] [Related]

  • 20. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation.
    Haikala H, Nissinen E, Etemadzadeh E, Levijoki J, Lindén IB.
    J Cardiovasc Pharmacol; 1995 May; 25(5):794-801. PubMed ID: 7630157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.